JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Novel Prognostic Markers for Skin Cutaneous Melanoma

  • 0Department of Dermatology, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot, People's Republic of China.
Clinical, Cosmetic and Investigational Dermatology +

|

November 26, 2024

|

November 26, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Researchers identified five novel prognostic genes for skin cutaneous melanoma (SKCM). The study highlights IL4I1

Area Of Science

  • Oncology
  • Genetics
  • Bioinformatics

Background

  • Skin cutaneous melanoma (SKCM) is a significant health concern.
  • Identifying novel therapeutic targets and prognostic biomarkers is crucial for SKCM management.

Purpose Of The Study

  • To identify pivotal genes involved in SKCM pathogenesis.
  • To evaluate the potential of these genes as prognostic biomarkers for SKCM.

Main Methods

  • Differential gene expression analysis on SKCM and normal skin samples.
  • Weighted gene co-expression network analysis (WGCNA) to identify hub genes.
  • Cox and overall survival analyses to assess prognostic value.

Main Results

  • Five novel prognostic genes (PLAC8, IL4I1, ZNF80, CCR8, CLEC4C) were identified for SKCM.
  • ZNF80 and CCR8 were confirmed as independent prognostic biomarkers.
  • Experimental validation showed downregulation of most identified genes in melanoma cells, except CCR8. IL4I1 knockdown promoted proliferation and inhibited apoptosis in melanoma cells.

Conclusions

  • The study identified potential prognostic genes for melanoma.
  • The functional role of IL4I1 in melanoma progression was experimentally validated.

Keywords: